We would like to thank Dr. Chiang for his scientific interest [1] in our recent cross-sectional study assessing the association between the presence and severity of MAFLD (assessed by ultrasonography and Fibrosis-4 index [FIB-4], i.e., one of the most commonly used non-invasive blood-based biomarkers for assessing advanced fibrosis) and the risk of supraventricular and ventricular tachyarrhythmias in patients with type 2 diabetes mellitus (T2DM), who underwent a 24-hour Holter monitoring for clinical indications [2]. Our responses to the comments raised by Dr. Chiang [1] are as follows
Reply to Dr. Chiang's comments
Targher, Giovanni
;Mantovani, Alessandro;
2023-01-01
Abstract
We would like to thank Dr. Chiang for his scientific interest [1] in our recent cross-sectional study assessing the association between the presence and severity of MAFLD (assessed by ultrasonography and Fibrosis-4 index [FIB-4], i.e., one of the most commonly used non-invasive blood-based biomarkers for assessing advanced fibrosis) and the risk of supraventricular and ventricular tachyarrhythmias in patients with type 2 diabetes mellitus (T2DM), who underwent a 24-hour Holter monitoring for clinical indications [2]. Our responses to the comments raised by Dr. Chiang [1] are as follows
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
